.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The NTR/prodrug cell ablation system represents a significant leap in chemogenetic technology. This method allows researchers to achieve precise spatiotemporal control over cell death within living organisms. By using bacterial nitroreductase (NTR) enzymes, scientists can convert non-toxic prodrugs into lethal cytotoxic agents. Consequently, this process induces targeted cell death only in specific, transgenic cell populations. While initially developed in mice, the system has seen extensive optimization in zebrafish due to their remarkable regenerative capabilities. Today, this tool is vital for studying how tissues recover from damage in real-time.
Recent technological shifts have dramatically expanded the utility of NTR/prodrug cell ablation. The introduction of NTR2.0, a rationally engineered enzyme variant, offers over 100-fold greater activity than earlier versions. Furthermore, the use of more potent prodrugs like ronidazole (RNZ) allows for effective ablation at much lower, well-tolerated concentrations. These improvements enable chronic disease modeling, which was previously difficult due to prodrug toxicity. Therefore, researchers can now simulate long-term degenerative conditions without harming the overall health of the model organism. This precision is essential for developing reproducible platforms in regenerative biology.
The NTR system is now a cornerstone for modeling various human pathologies. Researchers have successfully deployed these tools to study Parkinson's disease, retinal degeneration, and chronic kidney disease. By specifically ablating dopaminergic neurons or podocytes, scientists can observe the underlying mechanisms of pathogenesis in vivo. Additionally, these models serve as high-throughput screens for identifying pro-regenerative compounds. These findings could eventually lead to novel therapeutic strategies for managing human degenerative disorders. These best practices ensure that future studies remain both precise and versatile.
The system relies on transgenic design where the NTR enzyme is expressed only in specific cell types. When the prodrug is administered, only those cells can convert it into a toxic form, ensuring neighboring cells remain unharmed.
NTR2.0 exhibits significantly higher enzymatic activity, allowing for faster ablation kinetics and the use of lower prodrug doses. This minimizes side effects and enables the study of chronic, long-term disease states.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a substitute for professional healthcare consultation. Refer to the latest local and national guidelines for clinical practice.
References
1. Kim GJ et al. The NTR/prodrug revolution: Tools for controlling cell loss and regeneration. Elife. 2026 Jun 05. doi: undefined. PMID: 42246187.
2. Sharrock AV et al. NTR 2.0: a rationally-engineered prodrug converting enzyme with substantially enhanced efficacy for targeted cell ablation. bioRxiv. 2020. doi: 10.1101/2020.05.22.110593.
3. Draper I et al. Spatiotemporal control of cell ablation using Ronidazole with Nitroreductase in Drosophila. Methods Mol Biol. 2024. doi: 10.1007/978-1-0716-3401-1_15.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New advancements in the NTR/prodrug system, including NTR2.0, are enhancing our ability to model human diseases and study tissue regeneration in vivo....
last month
Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today
An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back
A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back
Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back
With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today
